Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Alice Durand"'
Autor:
Chiara Mazziotta, Carmen Lanzillotti, Roberta Gafà, Antoine Touzé, Marie-Alice Durand, Fernanda Martini, John Charles Rotondo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Merkel Cell Carcinoma (MCC) is a rare but highly aggressive form of non–melanoma skin cancer whose 5-year survival rate is 63%. Merkel cell polyomavirus (MCPyV), a small DNA tumor virus, is the etiological agent of MCC. Although representing a smal
Externí odkaz:
https://doaj.org/article/79436d05de3247a39cf5cb4eb68244d1
Autor:
Thomas Couronne, Paul Girot, Julien Hadoux, Thierry Lecomte, Alice Durand, Caroline Fine, Katia Vandevoorde, Catherine Lombard-Bohas, Thomas Walter
Publikováno v:
Endocrine Connections, Vol 9, Iss 6, Pp 498-505 (2020)
Objective: First-line chemotherapy in metastatic neuroendocrine carcinomas (NECs) is based on etoposide and platinum. However, there is no standard concerning second-line treatment. The objective of this study was to evaluate effic acy and tolerance
Externí odkaz:
https://doaj.org/article/86851713c3d2448bb59ddd470a1a72ef
Autor:
Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M. S. Hashemi, Florian Huemer, Anders Vikström, Martin Wermke, Gudrun Absenger, Alfredo Addeo, Shantanu Banerji, Antonio Calles, Stephen Clarke, Massimo Di Maio, Alice Durand, Michaël Duruisseaux, Malinda Itchins, Okko-Sakari Kääränien, Florian Krenn, Eckart Laack, Adrianus Johannes de Langen, Katja Mohorcic, Georg Pall, Antonio Passaro, Gerald Prager, Achim Rittmeyer, Jeffrey Rothenstein, Michael Schumacher, Ewald Wöll, Arschang Valipour
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Introduction: Rearranged during transfection (RET) gene fusions are rare genetic drivers in non-small cell lung cancer (NSCLC). Selective RET-inhibitors such as selpercatinib have shown therapeutic activity in early clinical trials; however, their ef
Externí odkaz:
https://doaj.org/article/fa3f18a7c5a247f2bb673138b510d84e
Autor:
Marie-Alice Durand, Aurélie Drouin, Alice Mouchard, Laurine Durand, Clara Esnault, Patricia Berthon, Anne Tallet, Yannick Le Corre, Ewa Hainaut-Wierzbicka, Astrid Blom, Philippe Saiag, Nathalie Beneton, Guido Bens, Charlee Nardin, François Aubin, Monica Dinulescu, Christine Collin, Gaëlle Fromont-Hankard, Bernard Cribier, Sara Laurent-Roussel, Kristof Cokelaere, Roland Houben, David Schrama, Paul Peixoto, Eric Hervouet, Kamel Bachiri, Diala Kantar, Etienne Coyaud, Serge Guyétant, Mahtab Samimi, Antoine Touzé, Thibault Kervarrec
Publikováno v:
Journal of Investigative Dermatology.
Autor:
Alice Durand, Caroline Fine, Paul Girot, Thierry Lecomte, Julien Hadoux, Thomas Couronne, Katia Vandevoorde, Thomas Walter, Catherine Lombard-Bohas
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 9, Iss 6, Pp 498-505 (2020)
Endocrine Connections, Vol 9, Iss 6, Pp 498-505 (2020)
Objective First-line chemotherapy in metastatic neuroendocrine carcinomas (NECs) is based on etoposide and platinum. However, there is no standard concerning second-line treatment. The objective of this study was to evaluate efficacy and tolerance of
Autor:
Matthieu Faron, Emmanuelle Leteurtre, S. Laboureau, Marie-Christine Rousselet, Christine Do Cao, Odile Blanchet, Igor Tauveron, Aude Marchal, Michel Ducreux, Arnaud Jannin, Valérie Hervieu, Guillaume Cadiot, Céline Gu, Eric Baudin, Caroline Petorin, Ségolène Hescot, Christina Kanaan, Juliette J. Zakeyh, Alice Durand, Julien Hadoux, Jean-Yves Scoazec, Thomas Walter, Vincent Hautefeuille, Denis Chatelain, Clément Beaulaton
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
Neuroendocrine carcinomas (NECs) are aggressive malignant diseases. Platinum-etoposide (PE) combination is the standard first-line treatment, whatever the primary location. The NEC score and also retinoblastoma protein (Rb) status have been suggested
Autor:
Alain Moreau, Martine Braibant, Julie Migraine, Marie-Alice Durand, Mélanie Bouvin-Pley, Philippe Roingeard, Aurélie Drouin, Julien Burlaud-Gaillard, Maxime Beretta
Publikováno v:
J Virol
Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that reduces HIV-1 infectivity by an incompletely understood mechanism. We show here that viruses differing only in the envelope glycoprotein (Env) expressed on their surface ha
Publikováno v:
APS – Division of Plasma Physics Nov 10, 2020. Session JO06: HED: Laboratory Astrophysics II (https://aps.org/meetings/meeting.cfm?name=DPP20).
Publikováno v:
American Physical Society - Division of Plasma Physics - November 9, 2020.